GDMH stands as fully owned entity of the Fondazione Policlinico Gemelli IRCCS, one of premier hospital in Italy and a global leader in healthcare. We are committed to propelling the development of digital medicine and health solutions, employing a dual approach as a Tech-Bio company and a Digital Healthcare Transformation Advisor and Enabler.
In our capacity as a Tech-Bio company, we harness cutting-edge technologies and data to innovate and execute digital health solutions. Our focus encompasses enabling Precision and Personalized Medicine treatments, supporting InSilico Trials and digital Clinical Trials operations, facilitating Molecule design with efficacy/safety prediction, aiding Biomarker discovery and predictive insights, and developing AI-based drug target identification & prioritization. Additionally, we contribute to new R&D strategies and methods.
As a digital healthcare transformation advisor and enabler, GDMH is dedicated to expediting the creation of value within new healthcare models for both public and private stakeholders. Our expertise is particularly valuable in contexts where medical/clinical practice and healthcare data play pivotal roles in shaping and leading Digital Medicine & Health (DM&H) strategy and Transformation Programs. We specialize in scouting and onboarding Digital Health alliances and partners, enabling the adoption and operation of DM&H solutions, and orchestrating the evolution of DM&H technology architecture. Ultimately, our efforts drive the realization of new patient journeys and outcome-based healthcare services.
The foundation of our success lies in the robust scientific pillars ingrained in the core of Fondazione Policlinico Gemelli IRCCS. These pillars encompass clinical expertise, data science, AI capabilities, clinical & omics data-lakes, and cutting-edge technologies. Each capability within these poles serves as a unique business and technological accelerator, empowering GDMH, along with its clients and partners, to transform the realms of Research & Development (R&D) and Digital Therapeutics (DTx).
At GDMH, the synergy of our team’s energy and passion propels ideas forward, placing the human factor as the most invaluable source of inspiration for groundbreaking innovations in the Digital Medicine Scenario. With an unwavering commitment to progress, we gaze ahead, marching towards the future of healthcare, all while keeping both patients and health professionals at the forefront of our journey.
